Le poste
Osivax is a clinical-stage biotechnology company that uses its oligoDOMTM technology platform to develop innovative vaccines. Osivax’ main project is a universal influenza vaccine that aims to revolutionize the prevention of seasonal influenza, currently in Phase 2a. OSIVAX is using this same technology to develop a broad-spectrum vaccine against SARS-COV-2, its variants or a new coronavirus pandemic. For more information, please visit their website: www.osivax.com OSIVAX has offices in France (Headquarters in Lyon) and Belgium (Affiliate in Liège). It is a growing company with over 40 employees.
As part of our development, we are looking for an:
Internship / Alternance: Competitive intelligence & Funding Manager (M/F)
-Lyon, France-
You will integrate an organization driven by innovation at the core of a biotech company business model. You interact within the Business Development & Strategy team whose challenge is to secure funding in the infectious disease area.
L'entreprise
Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM®, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses.
Domaine d'application
Fonction
Contrat
Expérience
Niveau d'étude
Localisation
Vous devez vous connecter à votre compte candidat pour postuler.